The additional targeting of hypoxia-inducing factors such as HIF1alpha or carbonic anhydrases may contribute to enhanced anti-tumour activity and reduce angiogenic resistance since it would target a different angiogenic pathway that contributes to the expression of VEGF and blood vessel formation. Here, VEGFA is linked to neoplasm.